These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 15713891

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.
    Dai Y, Liu M, Tang W, DeSano J, Burstein E, Davis M, Pienta K, Lawrence T, Xu L.
    Clin Cancer Res; 2008 Dec 01; 14(23):7701-10. PubMed ID: 19047096
    [Abstract] [Full Text] [Related]

  • 23. DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo.
    Mendonca MS, Turchan WT, Alpuche ME, Watson CN, Estabrook NC, Chin-Sinex H, Shapiro JB, Imasuen-Williams IE, Rangel G, Gilley DP, Huda N, Crooks PA, Shapiro RH.
    Free Radic Biol Med; 2017 Nov 01; 112():318-326. PubMed ID: 28782644
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer.
    Loriot Y, Mordant P, Dugue D, Geneste O, Gombos A, Opolon P, Guegan J, Perfettini JL, Pierre A, Berthier LK, Kroemer G, Soria JC, Depil S, Deutsch E.
    Cell Death Dis; 2014 Sep 18; 5(9):e1423. PubMed ID: 25232677
    [Abstract] [Full Text] [Related]

  • 28. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S, Almasan A.
    Cancer Res; 2003 Aug 01; 63(15):4713-23. PubMed ID: 12907654
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance.
    Oliver CL, Miranda MB, Shangary S, Land S, Wang S, Johnson DE.
    Mol Cancer Ther; 2005 Jan 01; 4(1):23-31. PubMed ID: 15657350
    [Abstract] [Full Text] [Related]

  • 31. Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bcl-2 expressing prostate cancer cells to irradiation.
    Cao W, Shiverick KT, Namiki K, Sakai Y, Porvasnik S, Urbanek C, Rosser CJ.
    World J Urol; 2008 Oct 01; 26(5):509-16. PubMed ID: 18594829
    [Abstract] [Full Text] [Related]

  • 32. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents.
    Mercatante DR, Mohler JL, Kole R.
    J Biol Chem; 2002 Dec 20; 277(51):49374-82. PubMed ID: 12381725
    [Abstract] [Full Text] [Related]

  • 33. Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancer.
    Anai S, Sakamoto N, Sakai Y, Tanaka M, Porvasnik S, Urbanek C, Cao W, Goodison S, Rosser CJ.
    Urol Oncol; 2011 Dec 20; 29(4):421-9. PubMed ID: 19576799
    [Abstract] [Full Text] [Related]

  • 34. Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.
    Dash R, Azab B, Quinn BA, Shen X, Wang XY, Das SK, Rahmani M, Wei J, Hedvat M, Dent P, Dmitriev IP, Curiel DT, Grant S, Wu B, Stebbins JL, Pellecchia M, Reed JC, Sarkar D, Fisher PB.
    Proc Natl Acad Sci U S A; 2011 May 24; 108(21):8785-90. PubMed ID: 21555592
    [Abstract] [Full Text] [Related]

  • 35. Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3.
    Inayat MS, Chendil D, Mohiuddin M, Elford HL, Gallicchio VS, Ahmed MM.
    Cancer Biol Ther; 2002 May 24; 1(5):539-45. PubMed ID: 12496485
    [Abstract] [Full Text] [Related]

  • 36. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Hahm ER, Arlotti JA, Marynowski SW, Singh SV.
    Clin Cancer Res; 2008 Feb 15; 14(4):1248-57. PubMed ID: 18281560
    [Abstract] [Full Text] [Related]

  • 37. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
    Cao W, Yacoub S, Shiverick KT, Namiki K, Sakai Y, Porvasnik S, Urbanek C, Rosser CJ.
    Prostate; 2008 Aug 01; 68(11):1223-31. PubMed ID: 18465755
    [Abstract] [Full Text] [Related]

  • 38. Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma.
    Mohammad RM, Wang S, Aboukameel A, Chen B, Wu X, Chen J, Al-Katib A.
    Mol Cancer Ther; 2005 Jan 01; 4(1):13-21. PubMed ID: 15657349
    [Abstract] [Full Text] [Related]

  • 39. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
    Cuellar DC, Rhee J, Kyprianou N.
    Anticancer Res; 2002 Jan 01; 22(3):1673-9. PubMed ID: 12168853
    [Abstract] [Full Text] [Related]

  • 40. Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression.
    Wong FY, Liem N, Xie C, Yan FL, Wong WC, Wang L, Yong WP.
    PLoS One; 2012 Jan 01; 7(12):e50786. PubMed ID: 23226540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.